Plain-English translation of NCT05594797 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Myeloma research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new therapy called (BCMA CAR-T) for patients with multiple myeloma that has returned or stopped responding to previous treatments. Researchers take some of your immune cells, modify them in a laboratory to better fight cancer, and then infuse them back into your body. The goal is to see if this treatment can help control the disease when other options have not worked.
Multiple myeloma is a serious blood cancer, and many patients eventually develop resistance to standard treatments. This trial exists to see whether this medication can offer new hope for patients whose cancer has become hard to treat.
You likely qualify if…
You likely don't qualify if…
First, you will have tests to confirm you qualify, including blood work, imaging scans, heart tests, and a physical exam. Then you will receive chemotherapy to prepare your body, followed by a one-time infusion of the modified immune cells. You may be hospitalized during parts of this process. After the infusion, you will be closely monitored in follow-up visits to watch for side effects and see how well the treatment works.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
China